Xencor, Inc. (XNCR) Social Stream



Xencor, Inc. (XNCR): $27.98

0.27 (+0.97%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add XNCR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 382

in industry

XENCOR INC (XNCR) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering XENCOR INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 6 $71 $49 $57.166 $27.71 106.3%
2021-11-12 6 $71 $49 $57.833 $27.71 108.71%
2021-12-12 6 $71 $49 $58 $27.71 109.31%
2022-01-02 7 $71 $49 $58.428 $27.71 110.86%
2022-02-08 8 $71 $49 $58.625 $27.71 111.57%
2022-02-14 9 $71 $49 $58.111 $27.71 109.71%
2022-03-22 9 $71 $49 $57.375 $27.71 107.06%
2022-04-10 9 $71 $49 $57.666 $27.71 108.11%
2022-05-06 8 $66 $48 $56.375 $27.71 103.45%
2022-05-27 8 $60.001 $42 $53.375 $27.71 92.62%
2022-06-06 8 $60 $42 $53.375 $27.71 92.62%
2022-07-06 9 $60 $42 $53 $27.71 91.27%
2022-08-04 9 $60 $35 $51.555 $27.71 86.05%
2022-09-21 10 $60 $35 $50.1 $27.71 80.8%
2022-10-13 10 $60 $35 $50.1 $27.71 80.8%
2022-11-08 10 $60 $35 $48.4 $27.71 74.67%
2022-11-09 10 $60 $35 $46.888 $27.71 69.21%
2023-01-31 10 $60 $35 $45.555 $27.71 64.4%
2023-02-10 10 $60 $35 $46.111 $27.71 66.41%
2023-02-24 11 $60 $36 $47.3 $27.71 70.7%

The Trend in the Analyst Price Target


XNCR's average price target has moved up $3.45 over the prior 33 months.

Over the past 47 weeks, XNCR's average upside potential has been 79.01%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-04-10 8 71.000 49 58.000 27.31 112.38%
2022-04-10 9 71.000 49 57.666 27.31 111.15%
2022-05-20 8 60.001 42 53.375 23.55 126.65%
2022-08-04 9 60.000 35 51.555 29.67 73.76%
2023-02-10 10 60.000 35 47.400 36.95 28.28%

XNCR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.09 10 1 0 0 0 11

The Trend in the Broker Recommendations


XNCR's average broker recommendation rating improved by 0.02 over the prior 26 weeks.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • XNCR has a greater upside potential (average analyst target price relative to current price) than 1865.28% of all US stocks.
  • XNCR has a greater average analyst price target than 1905.5% of Pharmaceutical Products stocks.
  • XENCOR INC's variance in analysts' estimates is lower than -699.24% of Pharmaceutical Products stocks.
  • To contextualize these metrics, consider that out of stocks in the mid market cap category, XENCOR INC's number of analysts covering the stock is higher than 1767.79% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to XENCOR INC are PAHC, RVNC, and SAGE.

What is the outlook for XNCR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6599 seconds.